Muscle loss in fatty liver disease
Part of Brain & nervous system clinical trials.
This study looks at whether people with fatty liver disease also have muscle loss, which can affect strength and overall health. It aims to help doctors better understand and treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with fatty liver disease (confirmed by imaging).
- You have at least one of these: a BMI of 25 or higher, a waist size over 94 cm (men) or 80 cm (women), high blood sugar, high blood pressure, high triglycerides, or low HDL cholesterol.
- You do not drink alcohol.
- You are not pregnant.
- You do not have hepatitis B or C, autoimmune hepatitis, cancer, or certain other serious conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This study looks at how fatty liver disease (related to metabolism) affects memory, strength, and quality of life—especially comparing men and women. It helps understand why some people with fatty liver feel more tired or have trouble thinking clearly.
This study looks at how certain features of your metabolism affect a simple score (called the FAST score) in people with fatty liver disease (MASLD). It aims to help doctors better understand and manage the condition.
This study tests if different types of exercise can reduce fat in the liver for people with metabolic fatty liver disease. It might help if you are looking for a non-drug way to improve your liver health.
This study aims to build a tool to predict how MASLD-related cirrhosis (fatty liver disease leading to liver scarring) will progress. It may help doctors and patients better understand the outlook and plan care.
Hear when a new Sarcopenia Among Patients With Metabolic Dysfunction-associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.